Privately-held Dewpoint Therapeutics, a Boston, USA, biotech developing therapeutics by targeting biomolecular condensates, ...

Chinese biotech Duality Biologics yesterday revealed that it has entered into an exclusive option agreement with UK pharma ...

Boston-based AI Proteins, a biotech that uses computational de novo protein design to create therapeutic miniproteins, has ...

Brexit by the ABPI, emphasizing the need for more resources and flexible licensing. The regulator faces challenges including ...

Cartesian Therapeutics reports positive Phase IIb results for Descartes-08 in generalized myasthenia gravis, achieving ...

UK’s MHRA is called to restore its reputation post-Brexit by the ABPI, emphasizing the need for more resources and flexible ...

The battle between the two front runners in the vast weight loss released top-line results from the SURMOUNT-5 Phase IIIb ...

Japanese drugmaker Ono Pharmaceutical has entered into a drug discovery collaboration agreement with privately-held Canadian ...

Refoxy Pharmaceuticals secures €9.1 million in seed-extension funding led by Boehringer Ingelheim Venture Fund to advance its ...

Spanish drugmaker PharmaMar Group revealed that its licensing partner, Luye Pharma Group, has received conditional marketing ...

Dutch privately held Amarna Therapeutics, which specializes in transformative gene therapies, has entered into a strategic ...

Maze Therapeutics secures $115 million in Series D funding to advance treatments for kidney and metabolic diseases with ...